SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001206774-22-001395
Filing Date
2022-05-09
Accepted
2022-05-09 16:20:54
Documents
14
Period of Report
2022-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT gern4058071-8k.htm   iXBRL 8-K 26883
2 PRESS RELEASE DATED MAY 9, 2022 gern4058071-ex991.htm EX-99.1 54358
6 GRAPHIC gern4058071-ex991x1x1.jpg GRAPHIC 8501
  Complete submission text file 0001206774-22-001395.txt   277420

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gern-20220509.xsd EX-101.SCH 2950
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20220509_pre.xml EX-101.PRE 22353
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20220509_lab.xml EX-101.LAB 34240
8 EXTRACTED XBRL INSTANCE DOCUMENT gern4058071-8k_htm.xml XML 3594
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 22905329
SIC: 2834 Pharmaceutical Preparations